Residency · Residency · Oral Maxillofacial Surgery
Antibiotic Stewardship in Oral and Maxillofacial Surgery
Introduction
Antibiotic stewardship — the judicious use of antimicrobial agents to optimize outcomes while minimizing resistance — is a critical responsibility for the OMFS surgeon. Oral and maxillofacial surgeons prescribe a significant volume of antibiotics for both prophylactic and therapeutic indications. Inappropriate prescribing contributes to antimicrobial resistance, adverse drug reactions, and Clostridioides difficile infection. This lecture reviews evidence-based antibiotic use in OMFS practice.
The Antimicrobial Resistance Crisis
Antimicrobial resistance (AMR) is recognized by the WHO as one of the top global health threats, with over 1.27 million deaths annually directly attributable to AMR worldwide. Dental prescriptions account for approximately 10% of all outpatient antibiotic prescriptions in the United States, and up to 50% of antibiotic prescriptions in dentistry are estimated to be unnecessary or inappropriate. Common resistance patterns relevant to OMFS include penicillin-resistant streptococci, beta-lactamase-producing anaerobes, and methicillin-resistant Staphylococcus aureus (MRSA).
Principles of Antibiotic Stewardship
Effective stewardship follows the principle of the right drug, selecting the narrowest-spectrum effective agent; the right dose, ensuring adequate dosing to achieve therapeutic concentrations; the right duration, prescribing the shortest effective course and avoiding unnecessarily prolonged therapy; and the right indication, prescribing only when a clear infectious indication exists. De-escalation involves transitioning from broad-spectrum to narrow-spectrum coverage based on culture results. Documentation of the indication, drug, dose, duration, and planned reassessment should accompany every antibiotic prescription.
Oral and Maxillofacial Microbiology
Odontogenic infections are polymicrobial, involving both aerobic and anaerobic organisms. Common aerobic pathogens include viridans group streptococci (particularly the Streptococcus anginosus group) and Staphylococcus species. Common anaerobic pathogens include Prevotella, Porphyromonas, Fusobacterium, Peptostreptococcus, and Bacteroides. As infection matures, the flora shifts from predominantly aerobic to anaerobic-predominant. Head and neck wound infections from trauma or post-surgical causes typically involve Staphylococcus aureus, streptococci, and gram-negative rods. Osteomyelitis is most commonly caused by S. aureus, with Actinomyces and polymicrobial organisms found in chronic cases.
Surgical Antibiotic Prophylaxis
Principles
Prophylactic antibiotics reduce surgical site infection (SSI) in clean-contaminated and contaminated procedures. They should be administered within 60 minutes before incision (30 minutes for IV; adequate oral absorption time for PO), and re-dosing is indicated for prolonged procedures exceeding 2 half-lives of the antibiotic or involving significant blood loss. Prophylaxis should be discontinued within 24 hours postoperatively, as extended prophylaxis beyond this does not reduce SSI and increases resistance.
OMFS-Specific Recommendations
| Procedure | Prophylaxis Indicated? | Recommended Regimen | Duration |
|---|---|---|---|
| Third molar extraction | Not routinely (healthy patients) | Amoxicillin 2 g PO if indicated | Single dose |
| Dental implant placement | Single preoperative dose | Amoxicillin 2 g PO | Single dose; no postop continuation |
| Orthognathic surgery | Yes | Ampicillin-sulbactam IV or penicillin + metronidazole | Discontinue within 24 hours |
| Open reduction facial fractures | Yes (clean-contaminated) | Ampicillin-sulbactam or cefazolin + metronidazole | Perioperative; discontinue within 24 hours |
| Mandible fractures (compound) | Yes; start at presentation | Ampicillin-sulbactam or penicillin + metronidazole | Perioperative; 24 hours postop |
| Head and neck oncologic surgery | Yes | Ampicillin-sulbactam IV | Extended to 24 hours |
For third molar extraction, prophylactic antibiotics are not routinely indicated in healthy patients; evidence supports their use only in cases with significant bone removal, immunocompromise, or elevated infection risk. For dental implant placement, a single preoperative dose of amoxicillin 2 g reduces implant failure, but postoperative continuation is not supported by evidence. Orthognathic surgery requires perioperative prophylaxis with IV ampicillin-sulbactam or penicillin plus metronidazole, discontinued within 24 hours. Open reduction of facial fractures is a clean-contaminated procedure when performed through oral mucosa, warranting perioperative prophylaxis with ampicillin-sulbactam or cefazolin plus metronidazole. For mandible fractures, antibiotics should be started at presentation for compound fractures and continued perioperatively, with a postoperative course of 24 hours being adequate for most cases. Head and neck oncologic surgery requires perioperative prophylaxis with ampicillin-sulbactam extended to 24 hours.
Therapeutic Antibiotic Use
Odontogenic Infections
| Severity | First-Line Agent | PCN-Allergy Alternative | Route | Duration |
|---|---|---|---|---|
| Mild-Moderate | Amoxicillin 500 mg TID or 875 mg BID | Clindamycin 300 mg QID or azithromycin 500/250 mg | PO | 5-7 days |
| Moderate-Severe | Amoxicillin-clavulanate 875/125 mg BID or amoxicillin + metronidazole | Clindamycin 300-450 mg QID + metronidazole | PO | 5-7 days |
| Severe (hospital) | Ampicillin-sulbactam 3 g IV q6h or piperacillin-tazobactam | Clindamycin IV + ceftriaxone | IV | Until clinical improvement; step-down to PO |
First-line therapy is amoxicillin 500 mg TID or 875 mg BID for mild to moderate infections. For penicillin-allergic patients, clindamycin 300 mg QID or azithromycin 500 mg on day 1 followed by 250 mg on days 2 through 5 is appropriate. Moderate to severe infections are treated with amoxicillin-clavulanate 875/125 mg BID or amoxicillin plus metronidazole. Severe hospital-based infections require IV therapy with ampicillin-sulbactam 3 g IV every 6 hours, piperacillin-tazobactam, or clindamycin IV. Duration is 5 to 7 days for most odontogenic infections, with reassessment at 48 to 72 hours. Critically, surgical source control through incision and drainage or extraction is paramount, as antibiotics serve only as an adjunct.
Deep Space Infections
Ludwig angina, parapharyngeal abscess, and retropharyngeal abscess require immediate surgical drainage and IV antibiotics. Empiric broad-spectrum coverage is initiated pending cultures, typically with ampicillin-sulbactam or clindamycin plus ceftriaxone. Aerobic and anaerobic cultures should be obtained at the time of incision and drainage, with de-escalation based on sensitivity results. Close monitoring for airway compromise is essential, as intubation or tracheostomy may be required.
Osteomyelitis
Chronic osteomyelitis of the mandible requires prolonged antibiotic therapy of 4 to 6 weeks, given IV or orally. Culture-directed therapy is essential, with empiric coverage targeting S. aureus and anaerobes. Surgical debridement of necrotic bone is the cornerstone of treatment, and consultation with infectious disease specialists is appropriate for complex or refractory cases.
Common Errors in Antibiotic Prescribing
Prescribing antibiotics for pulpitis (toothache without infection) is a frequent error, as antibiotics do not treat pain. Other common mistakes include extended postoperative prophylaxis beyond 24 hours for clean-contaminated procedures, using broad-spectrum agents when narrow-spectrum options are appropriate, failing to perform source control (incision and drainage, extraction) while relying solely on antibiotics, prescribing antibiotics for viral conditions such as herpetic stomatitis or viral pharyngitis, and not adjusting for antibiotic allergies due to inadequate allergy history.
Infective Endocarditis Prophylaxis
The AHA 2021 guidelines recommend prophylaxis only for patients at the highest risk of adverse outcomes from infective endocarditis. Cardiac conditions requiring prophylaxis include prosthetic cardiac valve, previous endocarditis, unrepaired cyanotic congenital heart disease, and cardiac transplant with valvulopathy. Procedures requiring prophylaxis are those involving manipulation of gingival tissue, the periapical region, or perforation of oral mucosa. The standard regimen is amoxicillin 2 g PO 30 to 60 minutes before the procedure, with clindamycin 600 mg or azithromycin 500 mg for penicillin-allergic patients.
Adverse Effects and Drug Interactions
Penicillins and amoxicillin cause rash in 5 to 10% of patients, with rare anaphylaxis, diarrhea, and C. difficile infection. Clindamycin carries the highest risk of C. difficile colitis among OMFS-prescribed antibiotics and should be used judiciously. Metronidazole causes a disulfiram-like reaction with alcohol, metallic taste, and peripheral neuropathy with prolonged use. Fluoroquinolones carry FDA black box warnings for tendon rupture, QT prolongation, and CNS effects, limiting their use for uncomplicated infections. Important drug interactions include metronidazole potentiating warfarin and macrolides interacting with statins and other CYP3A4 substrates.
Implementing Stewardship in Practice
Developing office-specific antibiotic protocols based on evidence-based guidelines is the foundation of effective stewardship. Tracking prescribing patterns and antibiotic utilization data enables ongoing quality improvement. Patient education should emphasize that antibiotics are not analgesics, that the prescribed course should be completed, and that medications should not be shared. Culture and sensitivity testing should be obtained for severe or refractory infections, and participation in continuing education on antimicrobial stewardship keeps practice current.
Clinical Pearls
Surgical source control through incision and drainage or extraction is the most important intervention for odontogenic infections, as antibiotics alone are insufficient. Prophylactic antibiotics for third molar extraction are not routinely indicated in healthy patients. Postoperative prophylaxis should not exceed 24 hours for any OMFS procedure. Clindamycin carries the highest risk of C. difficile infection and should be used only when clearly indicated. The indication, drug, dose, and planned duration should always be documented when prescribing antibiotics.
References
- Lodi G, et al. "Antibiotics to Prevent Complications Following Tooth Extractions." Cochrane Database of Systematic Reviews. 2021;2:CD003811.
- Wilson W, et al. "Prevention of Viridans Group Streptococcal Infective Endocarditis: AHA Scientific Statement." Circulation. 2021;143(20):e963-e978.
- Sancho-Puchades M, et al. "Antibiotic Prophylaxis in Oral Surgery and Dental Procedures." Medicina Oral, Patologia Oral y Cirugia Bucal. 2009;14(12):e643-e648.
- Dar-Odeh NS, et al. "Antibiotic Prescribing Practices by Dentists: A Review." Therapeutics and Clinical Risk Management. 2010;6:301-306.